Geometry Dash APK Hill Climb Racing APK
66.7 F
New York
Wednesday, April 21, 2021

Novavax, Inc. (NASDAQ:NVAX) Rebounds Ahead of Phase 1/2 Trial Data

Must read

Ozop Energy Solutions Inc (OZSC) is Riding a Green Wave of Momentum

Investors who are looking for fresh opportunities in rising stocks may have a lot to choose from at this point but it...

Drone Delivery Canada Corp (OTCMKTS:TAKOF) is Soaring after Roadmap Update

The drone industry has grown at a remarkable rate over the past five years or so and hence, it is no surprise...

Global Battery Metals Ltd (OTCMKTS:REZZF) in Focus: Trending Higher

Anyone who is tracking stocks that have made substantial gains over the course of the past month or so must not have...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Showing Strength After Patent Approval

Investors who believe in long-term wealth creation are often on the hunt for stocks that have recorded significant gains over a reasonable...

In recent times, Novavax, Inc. (NASDAQ:NVAX) has emerged as one of the better-performing stocks from the biotech sector. Earlier this year, the company announced significantly positive news with regards to NanoFlu, its flu vaccine product.

Investors are also awaiting data from the company’s Phase 1/2 trial, which is expected to be presented during the CDC ACIP meeting on October 30th

Coronavirus Play

However, it is as a ‘coronavirus play’ that the company has managed to really emerge as a winner as far as the stock price goes. Hence, it could be a good idea for investors to ponder if the Novavax stock can be a long term play or not.

In this regard, it is important to note that the company’s experimental COVID 19 vaccine NVX-CoV2373 is far from a sure thing yet. Many of the biggest pharmaceutical companies have paused their late-stage testing due to complications. Hence, it remains to be seen if Novavax’s vaccine manages to get emergency use authorization from the FDA.

On the other hand, NanoFlu is yet to get approval from the regulators. Hence, there is a significant degree of uncertainty with regard to Novavax’s two projects that have contributed to the rally this year.

Additionally, even if the two products are approved by the FDA, there is the possibility of similar vaccines from other companies proving to be more effective.

However, there is a certain degree of optimism about both products among experts. Additionally, if that happens, then the company could see revenue jump over the next five years. If it all pans out in that fashion, the Novavax could eventually be worth significantly more in half a decade and is worth keeping on the radar.

Latest article

Sysorex Inc (OTCMKTS:SYSX) Stock Still Riding Big News

Investors are always drawn to stocks that make a big jump out of nowhere. So it's no surprise that Sysorex Inc (OTCMKTS:SYSX)...

BIGG Digital Assets Inc (OTCMKTS:BBKCF) is Struggling to Regain Momentum

Over the course of the past few months, the continued rally in some of the biggest cryptocurrencies has led to considerable interest...

Sundial Growers Inc (NASDAQ:SNDL) Struggles to Sustain At Higher Levels After Earnings

In recent times, plenty of cannabis stocks have been in action due to rising optimism about the sector and one such stock...

HUMBL Inc (OTCMKTS:TSNPD) On the Rebound as Investors Track Developments

If there is one stock that has captured the imagination of many investors over the past months, then it's that of HUMBL...

88 Energy Limited Ltd (EEENF) Update: Continues Climbing on Significant Volume

Investors who might be looking for stocks that have made considerable gains in recent weeks could consider having a closer look at...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service